MAPS Public Benefit Corporation

Class 041: Educational services, namely, providing online and in-person experiential learning classes in the field of psychotherapy, and MDMA therapies and distribution of printed and electronic course materials in connection therewith

Class 042: Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, medical marijuana, plant-based medicines, psychedelic therapies; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies, medical marijuana; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes

Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, medical marijuana, plant-based medicines, psychedelic therapies; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies and medical marijuana; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes

Educational services, namely, providing online and in-person experiential learning classes in the field of psychotherapy and MDMA therapies and distribution of printed and electronic course materials in connection therewith

"PUBLIC BENEFIT CORPORATION"

"PUBLIC BENEFIT CORPORATION"

"PUBLIC BENEFIT CORPORATION"

"MDMA THERAPY TRAINING"

"PUBLIC BENEFIT CORPORATION"

Psychological research; Medical research; Scientific research; Pharmaceutical research; Research and development of medicines; Research and development of medicinal therapies; Medical and scientific research in the fields of psychotherapy, plant-based medicines, psychedelic therapies and FDA-approved medical marijuana; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of psychedelic research, psychotherapeutic treatments and therapies, MDMA therapies, LSD-assisted psychotherapy, Ibogaine-assisted treatment, Ayahuasca-assisted therapy and FDA-Approved medical marijuana; Conducting scientific feasibility studies; Technical research in the field of pharmaceutical studies; Technical consulting in the field of pharmaceutical studies; Research services for medical and pharmaceutical purposes

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.; Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.; THERAPEUTICS; Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.; Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Pharmaceutical preparations, namely, prescription psychedelic preparations and prescription psychotropics for the treatment of psychiatric and psychological diseases and disorders; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders

Pharmaceutical preparations, namely, prescription psychedelic preparations and prescription psychotropics; Psychotherapeutic preparations for managing and treating mental illnesses and other disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders